Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of MSC for inhibiting viral replication

A technology for virus replication and viral infection, applied in the direction of antiviral agents, medical raw materials derived from mammals, bone/connective tissue cells, etc. In vivo viral replication inhibition effect

Inactive Publication Date: 2020-08-11
HUNAN YUANPIN CELL TECH CO LTD
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently, there are currently no effective antiviral or immunomodulatory therapies for the treatment of SARS-CoV-2, although many clinical trials have begun

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of MSC for inhibiting viral replication
  • Application of MSC for inhibiting viral replication
  • Application of MSC for inhibiting viral replication

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] In order to enable those skilled in the art to better understand the technical solutions of the present invention, the present invention will be further described in detail below in conjunction with the accompanying drawings.

[0027] It should be noted that the original treatment plan mentioned in the present invention refers to the treatment plan adopted in the new coronavirus pneumonia diagnosis and treatment plan issued by the General Office of the National Health Commission and the Office of the State Administration of Traditional Chinese Medicine. MSC+ means the MSC treatment group , MSC- means the group without MSC treatment, Health means the healthy group.

[0028] Such as figure 1 As shown, in order to study the application of MSC for inhibiting virus replication, the invention provides a kind of specific steps for the application of MSC for inhibiting virus replication in patients with viral infection, including:

[0029] S1, prepare MSC preparation;

[0030...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention specifically discloses an application of MSC for inhibiting virus replication, especially an application of MSC for inhibiting virus replication of a viral infection patient, and relatesto the technical field of biomedical engineering. According to the invention, a prepared MSC preparation is added into an MSC treatment group to carry out combined treatment on the viral infection patient, so that ribosomal gene expression of the patient can be recovered to the level of health personnel after the MSC treatment group is healed, and virus replication can be effectively inhibited after the MSC treatment group is healed.

Description

technical field [0001] The invention relates to the technical field of biomedical engineering, in particular to an application of MSC for inhibiting virus replication. Background technique [0002] Viral infection refers to an infectious disease caused by a virus that can parasitize and reproduce in the human body. The main manifestations are systemic poisoning symptoms such as fever, headache, and general malaise, and local symptoms caused by inflammation and damage caused by the virus host and invading tissues and organs. Viral infections in the human body are divided into recessive infections, dominant infections, and lentiviral infections. Infection in most cases is recessive infection (refers to human body infection virus, no symptoms, but can produce specific antibodies). A few are overt infections (refers to the emergence of symptoms after the human body is infected with the virus). Among the overt infections, most viral infections manifest as acute infections with...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/51A61P31/14C12N5/0775
CPCA61K35/51A61P31/14C12N5/0665C12N2509/00C12N2509/10
Inventor 王文军黄险峰王明康禹欧阳智华王程李学林李珊
Owner HUNAN YUANPIN CELL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products